# A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical Care

> **NCT02236637** · — · COMPLETED · sponsor: **Janssen Pharmaceutica N.V., Belgium** · enrollment: 3050 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02236637
- **Lead sponsor:** Janssen Pharmaceutica N.V., Belgium
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-14
- **Primary completion:** 2018-11-21
- **Final completion:** 2018-11-21
- **Target enrollment:** 3050 (ACTUAL)
- **Last updated:** 2019-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02236637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02236637, "A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical Care". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02236637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*